title: [Economic and political aspects of prostate cancer prevention].
abstract: Deciding on a health policy in practice means dedicating human and financial resources and prioritising spendings. The economic evaluation of prevention strategies attempts to establish a relationship between the medical benefit of prevention and its additional cost (or in some cases cost reduction) compared to no prevention. Decisions on reimbursing drugs, interventions or funding health programmes do not usually follow efficiency criteria which define economic rationality. Politics may for example decide to make prostate cancer a public health priority if mortality in a country or in some regions of the country appears to be excessively high. Economic rationality alone is not an appropriate factor on which to base a decision which may be purely political, reflecting the actual values of the society at a given point in time.
authors.affiliation: Hôpital Henri-Mondor, AP-HP, Groupe Hospitalo-Universitaire Sud, Université Paris XII, Créteil, France. isabelle.durand-zaleski@hnm.ap-hop-paris.fr
authors.forename: I
authors.initials: I
authors.lastname: Durand-Zaleski
mesh_terms: D006801:Humans; D008297:Male; D011057:Politics; D011471:Prostatic Neoplasms / Q000191:economics* / Q000517:prevention & control*; D011640:Public Policy